Target
Fatty acid-binding protein, intestinal
Ligand
BDBM50152850
Substrate
n/a
Meas. Tech.
ChEMBL_305929 (CHEMBL833476)
IC50
1700±n/a nM
Citation
 Lehmann, FHaile, SAxen, EMedina, CUppenberg, JSvensson, SLundbäck, TRondahl, LBarf, T Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett 14:4445-8 (2004) [PubMed]  Article 
Target
Name:
Fatty acid-binding protein, intestinal
Synonyms:
FABP2 | FABPI | FABPI_HUMAN | Fatty acid binding protein intestinal | Fatty acid-binding protein, intestinal | I-FABP | Intestinal fatty acid-binding protein (hIFABP)
Type:
Protein
Mol. Mass.:
15207.56
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
132
Sequence:
MAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD
  
Inhibitor
Name:
BDBM50152850
Synonyms:
1-HEXYLDECANOIC ACID | CHEMBL82293 | Hexadecanoic acid | Hexadecanoic acid anion | Palmitic acid (PA)
Type:
Small organic molecule
Emp. Form.:
C16H32O2
Mol. Mass.:
256.4241
SMILES:
CCCCCCCCCCCCCCCC(O)=O
Structure:
Search PDB for entries with ligand similarity: